Large doses of methylcobalamin for juvenile muscular atrophy of distal upper extremity

Large doses of methylcobalamin for juvenile muscular atrophy of distal upper extremity - Methylcobalamin for juvenile muscular atrophy of distal upper extremity

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001284

Enrollment

Registered

2008-08-02

Start date

2008-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

juvenile muscular atrophy of distal upper extremity

Interventions

methylcobalamin 25mg/day (Day 1-10) methylcobalamin 25mg/day, every 4 weeks, 5 cycles methylcobalamin 1500 microg/day, 6 months

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients with amyotrophy 2) Written informed consent 3) Outpatient

Exclusion criteria

Exclusion criteria: 1) Patients with critical illness 2) Pregnant or lactating woman 3) Within 3 months from other clinical trial 4) Patients who are not appropriate to participate to the trial.

Design outcomes

Primary

Measure	Time frame
Overall Neuropathy Limitations Scale	—

Countries

Japan

Contacts

Public ContactSonoko Misawa

Chiba University Graduate School of Medicine Department of Neurology

sonoko.m@mb.infoweb.ne.jp043-222-7171

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026